Key Tax Considerations for External Capital Increase in the U.S. Subsidiary

U.S. Subsidiaries Accepting External Capital Increases More Than Just Signing an Agreement and Wiring Funds

Accepting an external capital increase by a U.S. subsidiary is not merely a matter of signing an agreement and wiring funds. Even minor oversights in the subsequent tax treatment of such inflows may trigger transfer pricing adjustments, challenges under the “thin capitalization” (capital weakness) doctrine, or even prompt follow-up audits by the Internal Revenue Service (IRS). As of 2026, the IRS has explicitly identified cross-border capital injections as one of its key audit focus areas-particularly where a Chinese parent company injects capital into its U.S. operating entity without concurrently updating capital structure documentation, establishes unreasonable interest payment arrangements, or deploys the funds in practice for purposes materially inconsistent with those declared to tax authorities. In practice, several cases have already arisen wherein ambiguous characterization of the nature of the capital increase led to disallowance of interest deductions, resulting in income tax adjustments plus statutory interest.

I. Characterization of the Capital Increase Determines the Entire Tax Liability Pathway

Funds contributed by a foreign shareholder to its U.S. subsidiary must first be clearly classified-as either “equity investment” or “debt arrangement.”

If characterized as a shareholder loan, the arrangement must satisfy the debt-to-equity ratio (“D/E ratio”) test. Under U.S. federal tax law, the minimum equity-to-debt ratio generally required is 11; certain states and specific industries impose even stricter thresholds. Should the D/E ratio exceed the permissible limit, excess interest payments may be recharacterized as dividends and subject to a 30% U.S. withholding tax-unless reduced or eliminated under an applicable income tax treaty.

Conversely, if properly classified as a capital contribution (i.e., equity), no taxable income arises in the year of contribution. However, the transaction must be accurately reported on Form 5471, including the amount of newly issued shares; subscription and actual payment dates; consideration type (cash vs. non-cash); and whether any special rights accompany the investment (e.g., liquidation preference, put rights, etc.).

II. Non-Cash Contributions Require Fair Market Value Appraisal and Deferred Recognition

Contributions made in the form of equipment, intellectual property, or domestic equity interests require a fair market value (FMV) appraisal conducted by a qualified third-party valuation firm whose methodology and report are acceptable under U.S. standards. The contributor must recognize gain (or loss) on the deemed transfer of assets in the year of contribution.

For example, in 2026, a semiconductor company contributed the right to use a domestic patent to its U.S. RD subsidiary, valuing it based on internal assumptions. Because it failed to provide a comparable license royalty rate analysis compliant with U.S. GAAP, the IRS challenged the valuation as understated-resulting in additional tax and interest totaling over USD 2.8 million.

Important note Contributions of intangible assets may also implicate anti-abuse provisions under IRC Section 367(d), necessitating advance planning regarding the technical transfer pathway.

III. Required Filing Documents (Compiled per IRS Operational Requirements)

1. Original capital increase agreement, accompanied by a certified English translation-including notarized signature pages;

2. Original minutes of the shareholders’ meeting and/or board of directors’ resolution, explicitly specifying the amount, method, timing, and intended use of the capital increase;

3. Bank wire advices or asset delivery/transfer documentation, clearly indicating the country of origin of the funds and the nature of the remittance (e.g., “capital contribution”);

4. Completed Form 5471 (Category 3 or Category 4, depending on control level), with Schedule M-1 attached to explain changes in the capital account;

5. For non-resident shareholders timely submission of Form W-8BEN-E and a Beneficial Owner Declaration;

6. Beneficial Ownership Information (BOI) filing with the Financial Crimes Enforcement Network (FinCEN) within 30 days following the capital increase.

IV. Ongoing Compliance Considerations from a Related-Party Transaction Perspective

Following the capital increase, all intercompany transactions-including service fees, royalties, and internal loans-must undergo recalibration of their transfer pricing documentation. The IRS’s 2026 Transfer Pricing Compliance Campaign explicitly requires that, within six months after any capital structure adjustment, taxpayers update the “Capital Structure Analysis” section in their local file and supplement the comparability analysis with sensitivity testing related to capital intensity. Failure to meet this deadline may jeopardize eligibility for the contemporaneous documentation exemption.

The above outlines key U.S. tax compliance considerations when a U.S. subsidiary accepts an external capital increase. We hope this guidance proves helpful. It is strongly recommended that, prior to execution, companies consult with tax advisors well-versed in both U.S. and Chinese tax regimes to jointly map out the funding pathway, review contractual terms, and coordinate filing timelines-thereby avoiding cascading tax risks arising from isolated oversights.